chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was vaccinated on 12/29/20, started having itching, redness, and swelling at injection site on 1/05/21. Went to ED on 01/08/21 with worsening itching, redness, and swelling at injection site. Treated in ED with steroids and sent home on oral steroids same day.
Given shot left arm pain. Pain has gone from arm to shoulder joint. Pain to touch and decrease range of motion.
Terrible migraine, 20 hours of sleep/trying to sleep along with throwing up a number of times.
On Thursday, 6/2/2016 pt received the following vaccines: Boostrix, Twinrix #2 and Imovax #3. That night, pt experienced "extremely sore / painfully achy arms from shoulders to hands" that improved over the course of the night. On Sunday, 6/5/2016, pt experienced the following symptoms: body aches in the upper legs/thighs, feet, back and buttox. These were temporarily relieved with a hot shower and tub soak. She also had a sore throat, swollen glands, light cough, nausea, lethargy, thirst, low appetite and a light headache. She felt much improved Monday 6/6/2016 and most of her symptoms had either completely resolved or diminished, although her sore throat and cough continued through 6/8/2016.
Developed suspected vaccinia lesions after expos. to a suspected vaccinia case (wrestling).  Also is household contact of recent smallpox vaccine.
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported.  The patient's concurrent conditions included irregular heartbeat, occasional chest pain, non smoker and non alcoholic. The patient did not have any drug abuse/illicit drug use and had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: 05-AUG-2021) dose was not reported, 1 total, administered on left arm on 07-APR-2021, 14:00 for prophylactic vaccination. Concomitant medications included bisoprolol for irregular heartbeat and isosorbide mononitrate for occasional chest pain.  On 21-JUL-2021, the patient had antibody tests (SARS-CoV-2 IgG antibody test) (NR: not provided) which resulted as negative (confirmed immunological vaccine failure). Laboratory test describes that, the assay detects spike protein of SARSCOV2 including the receptor binding domain (RBI)).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed immunological vaccine failure. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210745217- covid-19 vaccine ad26.cov2.s -CONFIRMED IMMUNOLOGICAL VACCINE FAILURE. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Patient was vaccinated in right arm. Within 5 to 10 seconds after vaccination, patient started clinching his hands tightly and became unresponsive. Patient was lowered to the floor and did not exhibit a pulse.  CPR was initiated and 911 was called.  An AED was used and healthcare professionals onsite continued compressions until the paramedics arrived.
This infant had an elevated temp 24 hours after her immunization (103.6 F) for 5 days. She vomited 1 day, diarrhea for 3 days, started on the 2nd day. She was given Tylenol and Motrin every 4 - 6 hours. Her symptoms resolved after 2 more days of clear liquid diet.
"Patient" was a perfectly healthy child until he received standard vaccines, most of which I have heard have been recalled. As a result, "patient" has and now suffers from extreme Autism.
Developed cough few days after vaccine, Barky, dry, persistent cough. 4 months later, she still cough. Saw allergy, asthma, and lung specialist. Treated with 3 sets antibiotics, 4 different cough syrups, double doses of steroids, Singulair, asthma inhalers, nothing helped.
immed hive following vax rt deltoid called ER put ice on area;later seen in ER;talked w/ER RN recommended allergy testing once arm cleared up;
24-hour fever, rapidly increasing to 103, before 1 gram acetaminophen reduced fever to 100.5. Two (2) additional 1-gram doses of acetaminophen were taken. Fever onset at about 4:00am 4/27, and broke about 4:00am 4/28. Additional symptoms include headache, chills, fatigue, soreness at injection site.  Almost resulted in clinic visit
12 hours after taking the second dose I experienced Chills, headache, fever flue like symptoms. 2 weeks after taking the second shot I am still experiencing  permanent flu like symptoms. burning sensation at both breading channels, and sinus has worsen clogging both nostrils making impossible to bread thru nose. have been using flu medication and overcounter sinus spry medicine. burning sensation makes impossible to stop snizing.
Redness spreading 3 days after vaccine; Itching spreading 3 days after vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 days after receiving Shingles vaccine, the patient experienced erythema and pruritus. On an unknown date, the outcome of the erythema and pruritus were unknown.   It was unknown if the reporter considered the erythema and pruritus to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient stated that the redness and itching was spreading 3 days after the Shingles vaccine. Additional supportive information: The follow-up would not possible, as no contact, details were available.
Almost immediately after COVID 19  vaccine administration,   patient began experiencing warmth ,dizziness and faint, variable breathing shallow, deep etc.  Cool compress applied to patient. Patient began to slump, tremors, and appeared to be passing out, eyes began to roll back. EPIPEN was administered and 911 was called.  The 911 medics arrived and patient was transported to emergency room .
Patient describes long standing fever that persisted for 30 days.  They experienced body chills.  They stated they ended up with the influenza A/B virus after getting the vaccine (tested 2 weeks after & verified positive for A/B at hospital per patient).   Patient states they lost their sense of taste and smell.  They state it caused their hands to turn blue.
Feb 4 ... tired, darkened skin on eyelids, muscle cramps left ankle Feb 5 ... extremely fatigue, eyelid discoloration worse, some confusion, no appetite  Feb 6 ... slept 11 hours, awoke to dizziness, nausea, diarrhea, eyelids discoloration improved, fatigued
Tired; Didn't feel well; red rash below the injection site; Nausea; Headache; Fever; Tachycardia; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia), MALAISE (Didn't feel well), VACCINATION SITE ERYTHEMA (red rash below the injection site), FATIGUE (Tired) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Tachycardia, Drug allergy (Codeine Allergy), Drug allergy (Sulfa drugs), Penicillin allergy, Drug allergy (Doxycycline allergy), Drug allergy (Z-Pack) and Epinephrine. Concomitant products included DEXLANSOPRAZOLE (DEXILANT), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TACHYCARDIA (Tachycardia). On 30-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red rash below the injection site), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). On an unknown date, the patient experienced MALAISE (Didn't feel well) and FATIGUE (Tired). On 29-Jan-2021, TACHYCARDIA (Tachycardia) had resolved. On 31-Jan-2021, NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) had resolved. On 06-Feb-2021, VACCINATION SITE ERYTHEMA (red rash below the injection site) had resolved. At the time of the report, MALAISE (Didn't feel well) had resolved and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: unknown (Inconclusive) SARCOV2 serology (covid-19) abigg and the results were positive..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not reported.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 2:46 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 2:46 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 28.45 for dose administered on 03-APR-2021.  No concomitant medications were reported.  Batch number 030B21A underwent temperature excursion on 03-APR-2021 with temperature 34 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 30-MAR-2021 and beyond use date for the vial was reported as 29-APR-2021. Product moved to clinic on 03-APR-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Information has been received from a physician concerning patient about 6 weeks old who on approximately September 2007 (reported as two months ago) was exposed to the grandmother who was vaccinated SC with a 0.65 mL dose of ZOSTAVAX (Oka/Merck) on September 2007 (reported as two months ago).  A day later after the grandmother was vaccinated, the patient "came down with chickenpox/"varicella" like rash."  The patient's status was not reported.  Additional information has been requested.
having an auto immune reaction / auto immune symptoms started roughly around 6 weeks; Pain all 4 extremities / complains of hands; Inflammation all 4 extremities / wrists Inflammed; Rheumatoid factor positive; hands including wrists painful and inflammed; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of AUTOIMMUNE DISORDER (having an auto immune reaction / auto immune symptoms started roughly around 6 weeks) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid factor. Concomitant products included METOPROLOL for Hypertension, PANTOPRAZOLE and VITAMINS NOS for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced AUTOIMMUNE DISORDER (having an auto immune reaction / auto immune symptoms started roughly around 6 weeks) (seriousness criterion medically significant), PAIN IN EXTREMITY (Pain all 4 extremities / complains of hands), INFLAMMATION (Inflammation all 4 extremities / wrists Inflammed), RHEUMATOID FACTOR POSITIVE (Rheumatoid factor positive) and ARTHRALGIA (hands including wrists painful and inflammed). The patient was treated with NAPROXEN SODIUM (ALEVE) for Antiinflammatory therapy, at an unspecified dose and frequency. At the time of the report, AUTOIMMUNE DISORDER (having an auto immune reaction / auto immune symptoms started roughly around 6 weeks), PAIN IN EXTREMITY (Pain all 4 extremities / complains of hands), INFLAMMATION (Inflammation all 4 extremities / wrists Inflammed), RHEUMATOID FACTOR POSITIVE (Rheumatoid factor positive) and ARTHRALGIA (hands including wrists painful and inflammed) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Blood test: abnormal (abnormal) auto immune reaction; with a positive CCP antibody and Rheumatoid Factor. On 01-Apr-2021, X-ray: normal (normal) Normal.         Company comment Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
The patient received a vaccine that was punctured and left at room temperature for greater than 24 hours; No adverse event; The vial was first punctured on 16-Nov-2022 at 9:00 am and administered on 17-Nov-2022 at 9:38 am; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was first punctured on 16-Nov-2022 at 9:00 am and administered on 17-Nov-2022 at 9:38 am), PRODUCT STORAGE ERROR (The patient received a vaccine that was punctured and left at room temperature for greater than 24 hours) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 013H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Nov-2022 at 9:38 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 17-Nov-2022 at 9:28 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was first punctured on 16-Nov-2022 at 9:00 am and administered on 17-Nov-2022 at 9:38 am). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The patient received a vaccine that was punctured and left at room temperature for greater than 24 hours) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vial was first punctured on 16-Nov-2022 at 9:00 am and administered on 17-Nov-2022 at 9:38 am), PRODUCT STORAGE ERROR (The patient received a vaccine that was punctured and left at room temperature for greater than 24 hours) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The vial was first punctured on 16-Nov-2022 at 9:00 am and administered on 17-Nov-2022 at 9:38 am) and PRODUCT STORAGE ERROR (The patient received a vaccine that was punctured and left at room temperature for greater than 24 hours).    No concomitant medications were provided. The dose was administered greater than 12 hours post puncture. The vial size was 2.5 ml. The reporter was not sure when it was thawed initially because their facility received it thawed with an expiration Date of 04-Dec-2022. The vial was first punctured on 16-Nov-2022 at 9:00AM. The vial was stored post puncture at room temperature. The vial did not undergo any temperature excursions. The vial was exposed to room temperature for  greater than 24 hours. Reporter says there has been no issues of symptoms No treatment medication was provided.
Patient symptoms interscapular back pain started 04/27/2021 upper extremeties weakness started late 4/27/2021 presented to ER on 4/28/2021 developed upper and lower extremeties weakness, urinary retention, multople imaging studies done, including MRI cervical and Thoracic spine, consistent with Transverse Myelitis
DONOR RECEIVED SHOT, WENT TO LOBBY TO WAIT 15 MINS. WAITED APPROX. 10 MINS. AND CAME TO OFFICE STATING HE FELT LIGHTHEADED AND SLIGHTLY NAUSEOUS, DONOR APPEARED PALE AND SLIGHTLY DIAPHORETIC. HAD DONOR SIT DOWN IN CHAIR, ICE PACK APPLIED TO BACK OF DONOR'S NECK, ASSISTED DONOR TO LIE DOWN ON BED. WHEN NAUSEA SUBSIDED OFFERED 8OZ JUICE AND CRACKERS TO DONOR DONOR FULLY RECOVERED IN APPROX 5-10 MINS. STATED FELT WELL AND HEALTHY, VS STABLE AND WAS RELEASED.
magnet stick to her arm, placed the magnet on her arm and wiggles it around and the magnet sticks, magnetic forces having an affect on her heart and other body parts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (magnet stick to her arm, placed the magnet on her arm and wiggles it around and the magnet sticks, magnetic forces having an affect on her heart and other body parts) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION COMPLICATION (magnet stick to her arm, placed the magnet on her arm and wiggles it around and the magnet sticks, magnetic forces having an affect on her heart and other body parts). At the time of the report, VACCINATION COMPLICATION (magnet stick to her arm, placed the magnet on her arm and wiggles it around and the magnet sticks, magnetic forces having an affect on her heart and other body parts) outcome was unknown.            Concomitant information use was not reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow up source document contains No New Information
Pfizer 9/15/21 and 10/13/21. Positive on 1/16/22
9 days after injection felt a bump in area of injection and developed a rash(01/162021).   11 days after injection developed the same rash on the lower inside of both legs.  No fever or other symptoms.
Started with extremely sore arm and noticeable dizziness on day 1. Each day had new symptoms. Day 2 I had headache, dizziness, sore arm, major sensitivity to light, confusion, and extreme thirst that could not be quenched.  Day 3 was more of the same but exhaustion was much worse. Day 4 had new symptoms, at night I had severe pelvic pain. So severe I would have gone to the ER if able. I did not sleep all night and Advil did not help. Day 5 I was still exhausted and still with pelvic pain but the pain was like an after effect pain, as if I had been injured internally and could feel all the bruising. This lasted for most of the day. I took Advil for the 2nd time. Day 6 I developed chills, still had headache and exhaustion. Day 7 Feeling a little better but not ready for normal activity. Day 8 Feeling almost normal, no headache but still weak.
I became short of breath, congested, body aches and all of the same issues I had when I had COVID-19. This in fact was more difficult to recover from.
I started to having ringing in the ears.  The treatment was HCTZ (Hydroclordiozide).  The results that I was diagnosed with was tinnitus in the ear but no resolution.
Mild reaction the first three days tired cold and achy but I was able to do my regular things. Yesterday was worse achy, headache, runny nose, scratchy throat, stuffy ears, head cold and the site started itching and now red and hot to touch.
I was very tired at 18:30 after receiving the vaccine at 14:29.  I went to bed at 18:30 that night awoke at 3 am for work and was still very tired and body aches.  I was driving to work and notice that I was having a delayed reaction to such things as I was looking at Christmas lights and had to remind myself I was driving.  The drive to work otherwise I do not remember.  I felt as if I was just not processing things around me correctly.  At work the symptoms were intermittent.  The thought process or lack of continued.  I began to have stomach pain felt like diarrhea coming on however I never had it.  Then nauseated and thought I was going to throw up and felt like I was going to pass out.   The passing out feeling continued until I had my coworker call a rapid because I knew my blood pressure was dropping and my hear rate became  slow and I was passing out.   I was then taken to the emergency room to where I continued to experience orthostatic blood pressure changes and bradycardia and hypotension.   I was given fluids and potassium IV and was feeling slightly better.   I went home and slept for the next 18 hours.   When I did briefly awaken through the evening I had an elevated temperature 102, chills and an extreme headache and body aches.    Today I awoke at 6 am and still sluggish with a slight headache and absolutely no appetite.
had 3 ischemic strokes; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 27Feb2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included antiphospholipid syndrome from an unknown date and unknown if ongoing. Concomitant medication included rivaroxaban (XARELTO) taken for an unspecified indication, start and stop date were not reported. On 19Mar2021, the patient was admitted to the hospital with stroke symptoms, it was determined that she had 3 ischemic strokes on 18Mar2021. The patient was hospitalized for the event from 19Mar2021 to an unknown date for 2 days. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 20Mar2021. Therapeutic measures were taken as a result of the event. The outcome of the event was recovered on an unspecified date.    Information on the lot/batch number has been requested.